Valeant Pharmaceuticals International (NYSE:VRX) today
announced that it will host a conference call on Thursday, November 3,
2005 at 10:00 a.m. ET (7:00 a.m. PT) to discuss results for the third
quarter of 2005.
The dial-in number to participate on this call is (877) 295-5743, confirmation code 1259446. International callers should dial (706) 679-0845, confirmation code 1259446. A replay will be available approximately two hours following the conclusion of the conference call through 12:00 a.m. ET on November 10, 2005, and can be accessed by dialing (800) 642-1687, confirmation code 1259446.
The company will also webcast the call live over the Internet, which will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to ten minutes prior to the call's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.
About Valeant
Valeant Pharmaceuticals International (NYSE:VRX) is a global, publicly traded, research-based specialty pharmaceutical company that discovers, develops, manufactures and markets products primarily in the areas of neurology, infectious disease and dermatology. More information about Valeant can be found at www.valeant.com.
The dial-in number to participate on this call is (877) 295-5743, confirmation code 1259446. International callers should dial (706) 679-0845, confirmation code 1259446. A replay will be available approximately two hours following the conclusion of the conference call through 12:00 a.m. ET on November 10, 2005, and can be accessed by dialing (800) 642-1687, confirmation code 1259446.
The company will also webcast the call live over the Internet, which will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to ten minutes prior to the call's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.
About Valeant
Valeant Pharmaceuticals International (NYSE:VRX) is a global, publicly traded, research-based specialty pharmaceutical company that discovers, develops, manufactures and markets products primarily in the areas of neurology, infectious disease and dermatology. More information about Valeant can be found at www.valeant.com.
© 2005 Business Wire
